Page 13 - Translational Sciences News Today

This crossover trial assesses whether high-sodium and low-sodium dietary interventions affect 24-hour ambulatory blood pressure measures among middle-aged to el

Updated data from azenosertib monotherapy study with longer follow up shows 37% ORR and mPFS of 6.5 months in heavily pretreated ovarian and uterine serous carcinoma patients Azenosertib programs on...

UCLA researchers have made headway using muscle stem cells to regrow damaged muscle in mice.

A study of multiple cohorts of patients with systemic lupus erythematosus showed significantly lower prevalence of antiphospholipid antibodies (aPLs) among Black patients.

Virpax® Pharmaceuticals, Inc. , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system disorders and anti-viral...

Inflammation is a risk factor for many chronic diseases, including cardiovascular disease (CVD), and the impact of diet on inflammation is an area of growing scientific interest.

The three companies are positioned to benefit from red-hot trends.

LONDON, Oct. 23, 2023 -- Mereo BioPharma Group plc , a clinical-stage biopharmaceutical company focused on rare diseases, today provided an update on recent program developments and third quarter...

Updated Covid vaccines based on Nobel prize-winning mRNA technology provide added protection — especially important when Covid-19, flu and RSV infections spike.

Poster presentations to include safety, efficacy, and biomarker data from Part A and B of the DRAGON trial in patients with advanced solid tumors treated with SRK-181 ...